EA200000584A2 - Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием - Google Patents

Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием

Info

Publication number
EA200000584A2
EA200000584A2 EA200000584A EA200000584A EA200000584A2 EA 200000584 A2 EA200000584 A2 EA 200000584A2 EA 200000584 A EA200000584 A EA 200000584A EA 200000584 A EA200000584 A EA 200000584A EA 200000584 A2 EA200000584 A2 EA 200000584A2
Authority
EA
Eurasian Patent Office
Prior art keywords
release pharmaceutical
controlled
pharmaceutical composition
thermoformable
solid
Prior art date
Application number
EA200000584A
Other languages
English (en)
Other versions
EA200000584A3 (ru
EA003751B1 (ru
Inventor
Патрик Вютриш
Эрве Роллан
Жилль Брио
Жераль Пишон
Франсуа Тарро
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547360&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200000584(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200000584A2 publication Critical patent/EA200000584A2/ru
Publication of EA200000584A3 publication Critical patent/EA200000584A3/ru
Publication of EA003751B1 publication Critical patent/EA003751B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

(57) Данное изобретение относится к новым твердым фармацевтическим композициям с контролируемым высвобождением, полученным тепловым формованием в горячем состоянии смеси, основанной на полимерах, принадлежащих к семейству полиметакрилатов, и медицинском активном ингредиенте (ингредиентах).
EA200000584A 1999-06-28 2000-06-27 Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием EA003751B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908210A FR2795326B1 (fr) 1999-06-28 1999-06-28 Composition pharmaceutique solide thermoformable a liberation controlee

Publications (3)

Publication Number Publication Date
EA200000584A2 true EA200000584A2 (ru) 2000-12-25
EA200000584A3 EA200000584A3 (ru) 2001-04-23
EA003751B1 EA003751B1 (ru) 2003-08-28

Family

ID=9547360

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000584A EA003751B1 (ru) 1999-06-28 2000-06-27 Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием

Country Status (23)

Country Link
US (1) US6319520B1 (ru)
EP (1) EP1064935B2 (ru)
JP (2) JP2001031591A (ru)
KR (1) KR100554899B1 (ru)
CN (1) CN1174744C (ru)
AT (1) ATE395045T1 (ru)
AU (1) AU765885B2 (ru)
BR (1) BR0002880A (ru)
CA (1) CA2312545C (ru)
CY (1) CY1110351T1 (ru)
DE (1) DE60038848D1 (ru)
DK (1) DK1064935T4 (ru)
EA (1) EA003751B1 (ru)
ES (1) ES2307489T5 (ru)
FR (1) FR2795326B1 (ru)
HK (1) HK1033435A1 (ru)
HU (1) HU229342B1 (ru)
NO (1) NO331449B1 (ru)
NZ (1) NZ505431A (ru)
PL (1) PL202494B1 (ru)
PT (1) PT1064935E (ru)
SI (1) SI1064935T2 (ru)
ZA (1) ZA200003245B (ru)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ510311A (en) * 1998-09-08 2003-08-29 Smithkline Beecham Corp Lipstatin derivative - soluble fiber tablets
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
FR2818550B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
US7862495B2 (en) 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US7247313B2 (en) * 2001-06-27 2007-07-24 Advanced Cardiovascular Systems, Inc. Polyacrylates coatings for implantable medical devices
US7175873B1 (en) 2001-06-27 2007-02-13 Advanced Cardiovascular Systems, Inc. Rate limiting barriers for implantable devices and methods for fabrication thereof
US6656216B1 (en) 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
GB0117619D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
US7622146B2 (en) * 2002-07-18 2009-11-24 Advanced Cardiovascular Systems, Inc. Rate limiting barriers for implantable devices and methods for fabrication thereof
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
MXPA05011071A (es) 2003-04-21 2005-12-12 Euro Celtique Sa Forma de dosificacion resistente a la alteracion que comprende particulas co-extrusionadas de agente adverso y proceso de fabricacion de las misma.
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
CA2524300C (en) 2003-08-08 2008-10-28 Biovail Laboratories International Srl Modified-release tablet of bupropion hydrochloride
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
CN1938004B (zh) 2004-03-30 2011-12-21 欧洲凯尔特公司 包含吸附剂和不利剂的抗篡改剂型
AU2005259961B2 (en) * 2004-06-25 2012-05-17 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
ES2427724T3 (es) * 2006-02-03 2013-10-31 Evonik Röhm Gmbh Composiciones farmacéuticas, que contienen mezclas de polímeros y de sustancias activas difícilmente solubles en agua
CA2646593C (en) * 2006-03-20 2015-12-08 Duramed Pharmaceuticals, Inc. Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
DE102007009242A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
JP4642134B2 (ja) * 2007-05-01 2011-03-02 コンサート ファーマシューティカルズ インコーポレイテッド ナフチル（エチル）アセトアミド
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
CN101481321B (zh) * 2009-02-27 2012-04-18 上海医药工业研究院 阿戈美拉汀卤化氢复合物及其制备方法
WO2012130837A1 (en) 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
EP2550863A1 (de) * 2011-07-27 2013-01-30 Bayer Intellectual Property GmbH Aktivstoffhaltige Partikel auf Polyacrylat-Basis
EA201490500A1 (ru) * 2011-08-30 2014-06-30 Университейт Гент Многослойный высвобождающий состав
CA2877410A1 (en) 2012-07-16 2014-01-23 Ratiopharm Gmbh Complex of agomelatine and cyclodextrin
JO3339B1 (ar) * 2012-09-11 2019-03-13 Shanghai Inst Pharmaceutical Ind شكل مستقر غير متبلور من الأغوميلاتين وعملية تحضيره والتركيبات الدوائية التي تحتوي عليه
KR101659983B1 (ko) 2012-12-31 2016-09-26 주식회사 삼양바이오팜 용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
EP2810656B1 (en) 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
CN103724415B (zh) * 2013-12-31 2015-05-27 中山大学 斜带石斑鱼性别调控基因Rspo1及其制备方法和应用
PT109154B (pt) * 2016-02-12 2019-11-05 Univ De Coimbra Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
FR3070619A1 (fr) * 2017-09-01 2019-03-08 Ab7 Innovation Piece moulee monolithique en matrice multiple pour la diffusion d’actifs et son procede d’obtention
EP3459527B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization
KR20200083500A (ko) * 2017-11-02 2020-07-08 이시하라 산교 가부시끼가이샤 서방성 의약 조성물
KR101856911B1 (ko) * 2017-12-13 2018-05-10 동국대학교 산학협력단 펠루비프로펜의 서방성 고체분산체 제제 및 이의 제조방법
CN109985025B (zh) * 2017-12-29 2023-01-13 沈阳药科大学 具有pH触发释药特征的眼部缓释给药系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
DE4138513A1 (de) † 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH11514979A (ja) † 1995-09-07 1999-12-21 フイズ テクノロジーズ リミテッド 実質的に非溶解性の生体作用薬剤をバイオ・アベイラブルにするシステム
DE19539362A1 (de) † 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von festen Arzneiformen
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
FR2766088B1 (fr) * 1997-07-17 2001-01-05 Dow Corning Sa Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee

Also Published As

Publication number Publication date
EP1064935B2 (fr) 2011-06-08
ES2307489T5 (es) 2011-11-07
DE60038848D1 (de) 2008-06-26
US6319520B1 (en) 2001-11-20
CY1110351T1 (el) 2015-04-29
EP1064935A1 (fr) 2001-01-03
PT1064935E (pt) 2008-07-03
AU765885B2 (en) 2003-10-02
FR2795326B1 (fr) 2001-08-31
NO20003349D0 (no) 2000-06-27
AU4273400A (en) 2001-01-04
HUP0002469A2 (en) 2002-06-29
CA2312545A1 (fr) 2000-12-28
BR0002880A (pt) 2001-01-30
HU0002469D0 (en) 2000-08-28
SI1064935T1 (sl) 2008-08-31
DK1064935T4 (da) 2011-09-26
ES2307489T3 (es) 2008-12-01
EP1064935B1 (fr) 2008-05-14
KR100554899B1 (ko) 2006-02-24
HU229342B1 (en) 2013-11-28
NZ505431A (en) 2002-12-20
CN1174744C (zh) 2004-11-10
DK1064935T3 (da) 2008-08-25
PL341042A1 (en) 2001-01-02
EA200000584A3 (ru) 2001-04-23
KR20010049643A (ko) 2001-06-15
NO20003349L (no) 2000-12-29
JP2006077033A (ja) 2006-03-23
CN1285188A (zh) 2001-02-28
NO331449B1 (no) 2012-01-02
SI1064935T2 (sl) 2011-12-30
HUP0002469A3 (en) 2008-04-28
ATE395045T1 (de) 2008-05-15
ZA200003245B (en) 2001-01-17
FR2795326A1 (fr) 2000-12-29
CA2312545C (fr) 2006-09-12
HK1033435A1 (en) 2001-08-31
PL202494B1 (pl) 2009-06-30
JP2001031591A (ja) 2001-02-06
EA003751B1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
BR9916835A (pt) Composição de galantamina de liberação controlada
MA30064B1 (fr) Formulation a liberation prolongee comprenant l'octreotide et deux copolymeres de polylactide-glycolide ou plus
BR0212921A (pt) Composição farmacêutica com base em fondant
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
NO20032737D0 (no) Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
PT1195160E (pt) Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
EA200400628A1 (ru) Таблетки метформина с контролируемым высвобождением активного компонента
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
BR0008739A (pt) Composições de liberação controlada debeta-histina
YU82693A (sh) Farmaceutske formulacije disulfonil metana i novi disulfonil metani
ES2170922T3 (es) Composicion farmaceutica a base de matrices lipofilas estabilizadas para la liberacion controlada de principios activos.
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
WO2002092552A3 (en) Benzamidoacetonitriles and their use as antiparasitics
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
EA200300664A1 (ru) Твердая термоформируемая фармацевтическая композиция для контролируемого высвобождения периндоприла
EP2266558A3 (en) Treatment of neuropathic pain with N-methyl-D-aspartate (NMDA) receptor antagonists
TR199900013T2 (xx) Yeni bile�ikler.
BR0212254A (pt) Composição farmaceutica
SE9803277D0 (sv) Novel compounds

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU